---
title: "美国药监局 FDA 批准吉利德一年两次的 HIV 预防注射剂，带来强效便捷的新选择"
description: "美国食品药品监督管理局（FDA）批准吉利德公司一年两次的抗病毒药物利那卡帕韦用于 HIV 预防，专家称此举为里程碑，可能有助于终结 HIV 疫情。然而，该药物上市面临特朗普政府提议削减 HIV 预防资金的威胁。"
type: "news"
locale: "zh-CN"
url: "https://longbridge.com/zh-CN/news/245150775.md"
published_at: "2025-06-18T18:35:02.000Z"
---

# 美国药监局 FDA 批准吉利德一年两次的 HIV 预防注射剂，带来强效便捷的新选择

> 美国食品药品监督管理局（FDA）批准吉利德公司一年两次的抗病毒药物利那卡帕韦用于 HIV 预防，专家称此举为里程碑，可能有助于终结 HIV 疫情。然而，该药物上市面临特朗普政府提议削减 HIV 预防资金的威胁。

美国食品药品监督管理局（FDA）批准了吉利德公司一年两次的抗病毒药物，用于预防 HIV。 该公司和一些专家表示，这是一个里程碑，可能有助于世界更接近终结这场持续数十年的 HIV 疫情。 然而，注射剂利那卡帕韦的上市面临着一系列潜在威胁，包括特朗普政府提议削减联邦政府对 HIV 预防工作的资金。

### Related Stocks

- [GILD.US - 吉利德科学](https://longbridge.com/zh-CN/quote/GILD.US.md)

## Related News & Research

| Title | Description | URL |
|-------|-------------|-----|
| Zimbabwe rolls out new HIV prevention drug lenacapavir | Zimbabwe has launched the long-acting HIV prevention drug lenacapavir, targeting over 46,000 high-risk individuals acros | [Link](https://longbridge.com/zh-CN/news/276333424.md) |
| Are Wall Street Analysts Predicting Keysight Technologies Stock Will Climb or Sink? | Are Wall Street Analysts Predicting Keysight Technologies Stock Will Climb or Sink? | [Link](https://longbridge.com/zh-CN/news/276353077.md) |
| Aris Mining Begins Trading on the New York Stock Exchange \| ARIS Stock News | Aris Mining Corporation has commenced trading on the New York Stock Exchange (NYSE) under the symbol "ARIS" after uplist | [Link](https://longbridge.com/zh-CN/news/276346344.md) |
| What the Options Market Tells Us About Analog Devices | Deep-pocketed investors are showing a bullish sentiment towards Analog Devices (NASDAQ:ADI), with 55% leaning bullish an | [Link](https://longbridge.com/zh-CN/news/276360337.md) |
| Hodges Capital Management Inc. Lowers Holdings in PowerFleet, Inc. $AIOT | Hodges Capital Management Inc. has reduced its stake in PowerFleet, Inc. (NASDAQ:AIOT) by 84% in Q3, now holding 172,515 | [Link](https://longbridge.com/zh-CN/news/276327245.md) |

---

> **免责声明**：本文内容仅供参考，不构成任何投资建议。